Abstract
BackgroundPatients with rheumatoid arthritis (RA) who respond well to biologics early in treatment tend to have better outcomes. Identifying baseline characteristics that predict early response may facilitate effective patient segmentation...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
